Research by Zhang et al. (2025) highlights the potential of incorporating the disintegrin and metalloproteinase domain-containing protein 10 (ADAM10), known to interact with key signalling and adhesion molecules, in the diagnosis and treatment of lung cancer [30]. Here, ADAM10 is linked to lung carcinoma.